Less CABG bleeding observed with enoxaparin compared with unfractionated heparin after PCI


A 0.5-mg/kg dose of a low molecular weight heparin, enoxaparin, resulted in less non-coronary-artery bypass grafting (CABG) bleeding compared with unfractionated heparin in the first 48 hours after elective percutaneous coronary intervention (PCI), according to a prospective, open-label, multicenter, randomized trial reported in the New England Journal of Medicine.

Related Content
© 2023 MJH Life Sciences

All rights reserved.